BiomX To Present Pre-clinical Data at the Plenary Session of the AACR Microbiome, Viruses, and Cancer Conference  

BiomX , a microbiome company developing both natural and engineered phage therapies, today announced that the company will present pre-clinical data from its colorectal cancer program at the plenary session of the American Association for Cancer Research (AACR) Microbiome, Viruses, and Cancer Conference taking place from February 21-24, 2020, in Orlando, Florida.